Skip to main content Skip to navigation

Professor Steve Smerdon

Steve Smerdon

Contact Details

Professor Steve Smerdon

Institute of Cancer and Genomic Sciences, University of Birmingham

 

Research Interests

For the last 20 years or so our primary interest has been in the significance of phosphorylation as a reversible molecular ‘switch’ for multi-protein complex assembly, with a major focus on signalling events that regulate the response to highly genotoxic double-stranded DNA breaks.

Our work has produced the first structures of 14-3-3 proteins (Cell 1997), FHA domains from Chk2 and its yeast orthologue Rad53 (Molecular Cell 2000 & 2002), the Polo-box domain from human Plk1 kinase (Cell 2003), Mob1-family proteins (Science 2013) and BRCT-repeat domains from human Brca1 and Mdc1 (NSMB 2004 & Cell 2005), all in complex with phosphorylated motifs from interacting partners. These structural firsts include a much anticipated study of the FHA-BRCT-repeat region of the Nbs1 signalling component of the DNA break repair ‘MRN’ complex (Cell 2009), More recently, we have used electron microscopy and ion-mobility mass spectrometry to describe the overall architecture of the core hetero-octameric Brca1-A histone deubiquitinase complex, providing some intriguing insights into substrate binding and mechanisms of phospho-dependent Brca1-mediated regulation (Cell Reports 2016).

Current projects build on and extend these previous studies and include:

  • Nbs1 structure-function relationships in interactions with Mdc1 and other factors.
  • Structure, assembly and regulation of Brca1 complexes.
  • Chk2 kinase activation and identification of novel substrates and effectors.
  • New chemical/synthetic biology and mass spectrometry approaches for identification of novel DNA damage-dependent interactions and functional DNA-damage phosphosite annotation.
  • Interplay between phosphorylation, ubiquitylation and sumoylation in cell proliferation and apoptosis.

Project Details

Professor Steve Smerdon is supervising no projects this year.